Learning objectives
To provide knowledge of the aims and methodologies adopted for the preclinical evaluation of the toxicological profile of drugs, with particular reference to biotechnology-derived pharmaceuticals
Prerequisites
- - -
Course unit content
Safety assessment of biotechnology-derived pharmaceuticals:<br />
<ol>
<li>Single-dose and repeated-dose toxicity studies</li>
<li>Reproductive and developmental, genotoxicity and carcinogenicity toxicity studies</li>
<li>Safety pharmacology</li>
</ol>
Examples of preclinical studies of biotechnology-derived pharmaceuticals.
Full programme
- - -
Bibliography
Ballantyne B., Marrs T.C. General and applied toxicology. London, MacMillan (1993).<br />
Klaassen C. Casarett and Doull’s toxicology. McGraw-Hill Italia (2008).
Teaching methods
- - -
Assessment methods and criteria
- - -
Other information
- - -